Oct 18, 2024 / 08:00AM GMT
Operator
Welcome to the Getinge Q3 report 2023. (Operator Instructions) Now I will hand the conference over to the speakers, CEO Mattias Perjos and CFO Agneta Palmér. Please go ahead.
Mattias Perjos - Getinge AB - President, Chief Executive Officer, Director
Thank you very much, and thanks, everyone, for joining today. We can move directly to page number 2 and the key takeaways from the quarter, please.
So we look back at a quarter where we continue to see strong global market momentum for our products. Order intake growth for Getinge as a whole increased by 10 percentage points, of which organic growth amounted to 7.4%. And this is thanks to positive development in all business areas, except for life science, and it's a good geographic spread as well when it comes to the order intake.
Net sales increased by 3.5% in the quarter, where organic growth was flat to last year. Adjusted gross margin in life science and surgical workflows improved in the quarter. However, it decreased in acute care therapies and also for the group as a consequence of this,
Q3 2024 Getinge AB Earnings Call Transcript
5 days ago
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers